HLA-G and ovarian cancer: designed and tested a CAR strategy to target HLA-G in solid tumors, and the results showed that HLA-G CAR-transduced NK cells effectively cytolyzed breast, brain, pancreatic and ovarian cancer cells in vitro and resulted in reduced xenograft tumor growth with extended median survival in orthotopic mouse models (133).